Some large European and U.S. vaccine maker stocks have fallen in reaction to Robert F. Kennedy Jr.’s nomination to lead the Department of Health and Human Services.
Kennedy has been known to be against vaccines and has a track record of making false claims about vaccines, including the debunked idea that they cause autism. Scientific studies have debunked this theory.
Also, given his critical stance on mainstream medical practices and vaccines, U.S. Food and Drug Administration (FDA) and National Institutes of Health (NIH) employees are worried about Kennedy being in charge.
Kennedy, who received Trump’s blessing to “go wild on health,” has stated intentions to overhaul various aspects of the federal health agencies.
On Friday, the World Health Organization also defended vaccines describing them as “absolutely critical” to global health, adding that many people alive today would not have survived childhood without them.
GSK stock fell after the company reported lower third-quarter sales, which was impacted by an 18% decline in vaccine sales.
Other vaccine players’ stocks that are down include Merck & Co Inc (NYSE:MRK) and Inovio Pharmaceuticals, Inc (NASDAQ:INO).
Price Action: GSK stock is down 3.88% at $33.06, BNTX stock is down 5.18%, VALN stock is down 4.24%, AZN stock is down 2.08%, MRK stock is down 3.28%, INO stock is down 9.85% at last check Friday.
Read Next:
Photo by Vladimka production via Shutterstock
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
